Oliver Howes
Howes, Oliver D.
Howes, Oliver
Howes, Oliver (Oliver D.)
VIAF ID: 311812929 (Personal)
Permalink: http://viaf.org/viaf/311812929
Preferred Forms
- 100 1 _ ‡a Howes, Oliver
-
- 100 1 _ ‡a Howes, Oliver
- 100 1 _ ‡a Howes, Oliver D.
-
-
-
- 100 1 _ ‡a Howes, Oliver ‡q (Oliver D.)
-
- 100 0 _ ‡a Oliver Howes
4xx's: Alternate Name Forms (4)
Works
Title | Sources |
---|---|
effects of voice content on stress reactivity : a simulation paradigm of auditory verbal hallucinations | |
Handbook for psychiatric trainees, c2008: | |
The impact of Disrupted-in-Schizophrenia 1 (DISC1) on the dopaminergic system: a systematic review. | |
impact of the prolonged COVID-19 pandemic on stress resilience and mental health: A critical review across waves | |
Impaired Glucose Homeostasis in First-Episode Schizophrenia: A Systematic Review and Meta-analysis. | |
The importance of venous thromboembolism - a physical consequence of psychiatric treatments | |
Inflammation and the neural diathesis-stress hypothesis of schizophrenia: a reconceptualization | |
Interpersonal sensitivity in the at-risk mental state for psychosis. | |
Interpreting the neurodevelopmental hypothesis of schizophrenia in the context of normal brain development and ageing | |
Is antipsychotic treatment linked to low bone mineral density and osteoporosis? A review of the evidence and the clinical implications | |
Is clinical intervention in the ultra high risk phase effective? | |
Is psychosis a multisystem disorder? A meta-review of central nervous system, immune, cardiometabolic, and endocrine alterations in first-episode psychosis and perspective on potential models | |
Johann Cristian Reil on the 200th anniversary of the first description of the insula | |
Julius Wagner-Jauregg, 1857-1940. | |
Limbic striatal dopamine D2/3 receptor availability is associated with non-planning impulsivity in healthy adults after exclusion of potential dissimulators | |
The link between dopamine function and apathy in cannabis users: an [18F]-DOPA PET imaging study. | |
Long-Term Heavy Ketamine Use is Associated with Spatial Memory Impairment and Altered Hippocampal Activation. | |
Longitudinal PET imaging in a patient with schizophrenia did not show marked changes in dopaminergic function with relapse of psychosis | |
Magnitude and heterogeneity of brain structural abnormalities in 22q11.2 deletion syndrome: a meta-analysis | |
manongarivo Environmentally friendly health care begins in Madagascar | |
Mapping vulnerability to bipolar disorder: a systematic review and meta-analysis of neuroimaging studies | |
Measuring endogenous changes in serotonergic neurotransmission in humans: a [11C]CUMI-101 PET challenge study. | |
A Meta-analysis of Immune Parameters, Variability, and Assessment of Modal Distribution in Psychosis and Test of the Immune Subgroup Hypothesis | |
Midbrain dopamine function in schizophrenia and depression: a post-mortem and positron emission tomographic imaging study | |
Mind the mortality gap: the importance of metabolic function in mental illnesses | |
Mind the translation gap: problems in the implementation of early intervention services. | |
Misattributing speech and jumping to conclusions: a longitudinal study in people at high risk of psychosis. | |
Molecular imaging as a guide for the treatment of central nervous system disorders | |
Molecular imaging studies of the striatal dopaminergic system in psychosis and predictions for the prodromal phase of psychosis | |
Multimodal functional imaging investigation before and after the onset of psychosis | |
Nature or nurture? Determining the heritability of human striatal dopamine function: an [18F]-DOPA PET study | |
Neural and behavioral correlates of aberrant salience in individuals at risk for psychosis | |
Neuropathological changes in the substantia nigra in schizophrenia but not depression. | |
Opposite effects of catechol-O-methyltransferase Val158Met on cortical function in healthy subjects and patients with schizophrenia. | |
Partial volume correction using structural-functional synergistic resolution recovery: comparison with geometric transfer matrix method | |
Pathways to schizophrenia: the impact of environmental factors | |
A potential biomarker for treatment stratification in psychosis: evaluation of an [18F] FDOPA PET imaging approach | |
Practitioner attitudes to clozapine initiation | |
Predicting brain occupancy from plasma levels using PET: superiority of combining pharmacokinetics with pharmacodynamics while modeling the relationship | |
The predictive power of brain mRNA mappings for in vivo protein density: a positron emission tomography correlation study | |
Presynaptic 5-HT1A is related to 5-HTT receptor density in the human brain | |
Presynaptic dopaminergic function: implications for understanding treatment response in psychosis | |
Presynaptic Serotoninergic Regulation of Emotional Processing: A Multimodal Brain Imaging Study. | |
Presynaptic striatal dopamine dysfunction in people at ultra-high risk for psychosis: findings in a second cohort. | |
Prevalence and implications of Truman symptoms in subjects at ultra high risk for psychosis | |
Prevalence of serum N-methyl-D-aspartate receptor autoantibodies in refractory psychosis | |
Progressive increase in striatal dopamine synthesis capacity as patients develop psychosis: a PET study. | |
Przegląd danych klinicznych : postępowanie w przypadku schizofrenii lekoopornej - model opieki według Maudsley Treatment Review and Assessment Team = Clinical overview : the practical management of refractory schizophrenia - the Maudsley Treatment Review and Assessment Team service approach | |
Pseudohallucinations Versus True Hallucinations in Prodromal Psychosis | |
Quantification of ligand PET studies using a reference region with a displaceable fraction: application to occupancy studies with [(11)C]-DASB as an example | |
Reduced mismatch negativity predates the onset of psychosis. | |
Regulation of dopaminergic function: an [18F]-DOPA PET apomorphine challenge study in humans. | |
The relationship between antipsychotic D2 occupancy and change in frontal metabolism and working memory : A dual [(11)C]raclopride and [(18) F]FDG imaging study with aripiprazole | |
The relationship between prolactin levels and glucose homeostasis in antipsychotic-treated schizophrenic patients | |
The relationship between reward and punishment processing and the 5-HT1A receptor as shown by PET. | |
The relationship between synaptic density marker SV2A, glutamate and N-acetyl aspartate levels in healthy volunteers and schizophrenia: a multimodal PET and magnetic resonance spectroscopy brain imaging study | |
Reply to: Hippocampal Glutamate Levels and Striatal Dopamine D 2/3 Receptor Occupancy in Subjects at Ultra High Risk of Psychosis | |
Resting Hyperperfusion of the Hippocampus, Midbrain, and Basal Ganglia in People at High Risk for Psychosis. | |
Schizophrenia: an integrated sociodevelopmental-cognitive model | |
Sensory gating deficits in the attenuated psychosis syndrome. | |
The serotonin transporter in depression: Meta-analysis of in vivo and post mortem findings and implications for understanding and treating depression. | |
Serum glutamic acid decarboxylase 65 antibody levels in people with schizophrenia and their families | |
Sexual dysfunction in people with prodromal or first-episode psychosis. | |
Sexual function and gonadal hormones in patients taking antipsychotic treatment for schizophrenia or schizoaffective disorder. | |
Single cocaine exposure does not alter striatal pre-synaptic dopamine function in mice: an [18 F]-FDOPA PET study. | |
Spatial working memory ability in individuals at ultra high risk for psychosis | |
Stress resilience during the coronavirus pandemic | |
Striatal dopamine synthesis capacity in twins discordant for schizophrenia | |
Striatal dopamine transporter availability in drug-naive patients with schizophrenia: a case-control SPECT study with [(99m)Tc]-TRODAT-1 and a meta-analysis | |
The synaptic hypothesis of schizophrenia version III: a master mechanism | |
Task-induced functional brain connectivity mediates the relationship between striatal D2/3 receptors and working memory | |
The test-retest reliability of 18F-DOPA PET in assessing striatal and extrastriatal presynaptic dopaminergic function | |
Test-retest reproducibility of cannabinoid-receptor type 1 availability quantified with the PET ligand [¹¹C]MePPEP. | |
Transition to psychosis associated with prefrontal and subcortical dysfunction in ultra high-risk individuals | |
Translation and cross-cultural adaptation of the Sexual Function Questionnaire (SFQ) into Brazilian Portuguese | |
Treating negative symptoms of schizophrenia: current approaches and future perspectives | |
Treatment resistant or resistant to treatment? Antipsychotic plasma levels in patients with poorly controlled psychotic symptoms | |
Treatment response and resistance in schizophrenia | |
'Truman' signs and vulnerability to psychosis. | |
Understanding pathophysiology is crucial in linking clinical staging to targeted therapeutics | |
The use of healthy volunteers instead of patients to inform drug dosing studies: a [11C]raclopride PET study | |
Very Early Brain Damage Leads to Remodeling of the Working Memory System in Adulthood: A Combined fMRI/Tractography Study | |
Vitamin D deficiency in first episode psychosis: a case-control study |